a prescription for improving drug formulary decision making改善药物处方规定的决策.pdfVIP

a prescription for improving drug formulary decision making改善药物处方规定的决策.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a prescription for improving drug formulary decision making改善药物处方规定的决策

Policy Forum A Prescription for Improving Drug Formulary Decision Making Gordon D. Schiff1,2*, William L. Galanter2,3,4, Jay Duhig2,5, Michael J. Koronkowski2,5, Amy E. Lodolce2,5, Pam Pontikes2,6, John Busker2,6, Daniel Touchette2,5, Surrey Walton2,5, Bruce L. Lambert2,4,5 1 Brigham and Woman’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 2 Center for Education and Research on Therapeutics, University of Illinois at Chicago, Chicago, Illinois, United States of America, 3 University of Illinois at Chicago, College of Medicine, Chicago, Illinois, United States of America, 4 Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, United States of America, 5 University of Illinois at Chicago, Department of Pharmacy Administration, Chicago, Illinois, United States of America, 6 John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, United States of America Introduction efficacious, safest, and cost-effective ther- faced with packed meeting agendas that apies, while serving as a firewall to protect never seemed to permit sufficient time to Drug formularies are a ubiquitous, against prescribing overly driven by mar- thoroughly explore decision pros and heterogeneous yet often contentious fea- keting claims [11–13,16–21]. Through the cons, monitoring requirements, and opti- ture of both US and international drug decision-making activities of the formulary mal usage for proposed new drugs, we policy [1–6]. Formularies represent the process, knowledge and leverage may be observed that discussions were often fundamental

您可能关注的文档

文档评论(0)

qianqiana + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5132241303000003

1亿VIP精品文档

相关文档